Fiser Chaper 2. HEMATOLOGY Flashcards
Intrinisic pathway
-Exposed collagen, prekallikrein, HMW kininogen, factor 7
–> activate 11
–> activate 9, then add 8
-> activate X, then add V
–> contvert prohrombin (2) to thrombin
-> thrombin converts fibrinogen to fibrin
Extrinisic pathway
Injured cells: tissue factor + 7
- > convert prothrombin to thrombin
- > thrombin converts fibrinogen to fibrin
Prothrombin complex
10, 5, calcium, platelet facotr 3, prothrombin
Forms on platelets
Catalyzes the formation of thrombin
What is the convergent point for intrinsic and extrinsic pathways
X
Tissue factor pathway inhibitor does what?
Inhibits factor 10
Factor13 does what?
Helps crosslink fibrin
Fibrin dose what?
Binds GpIIb/IIIa molecule to link platelets together and form platelet plug
Thrombin does what?
Key to coagulation
COnverts fibrinogen to fibrin and fibrin split products
Activates 5 and 13, and platelets
Key to normal AC?
Antithrombin III
What does AT-III do?
Key to anticoagulation
Binds and inhibits Thrombin
Also inhibits 9, 10, 11
How does heparin work?
Activates AT-III (up to 1000x normal activity)
Protein C and S
Both vitamin K dependent
C: decreades 5and 8 and fibrinogen
S: protein Ccofactor
Fibrinolysis needs what?
Tissue plasminogen activator: released from endothelium and converts plasminogen to plasmin
–> Plasmin degrades factors 5, 8, fibrinogen, fibron
–> lose platelet plug
Alpha-2 antiplasmin
Natural inhibitor of plasmin, released from endothelium
Shortest half life factor?
7
Only factor not synthesized in liver?
8 (endothelium)
Vit K dependent factors
2, 7, 9, 10, C and S
How long does vit k take?
6 hours to have effect
How long does FFP take?
Immediate, lasts 6 hours
Half life of RBCs, platelets, PMNs
RBCs: 120 days
Platelets: 7 days
PMNs: 1-2 days
PGI2
prostacyclin
from endothelium
decreases platelet aggregation and promotes vasodilation
antagonist to TXA2
TXA2
Thromboxane
From platelets
Increases platelets aggregation and vasoconstriction
Triggers release of calciumin platelets –> exposes GpIIb/IIIa receptor and causes platelet-to0platelet binding; platelet-to-collagen binding also occurs (Gp1b receptor)
Cryoprecipitate
highest conc of vWF-8; also has fibrinogen
used in vWF disease and hemophilia A
FFP
all coag factors, C, S, AT-III
DDAVP and conjugated estrogens
Cause release of 8 and vWF from endothelium
PT
measures 2, 5, 7, 10, fibrinogen; best for liver synthetic function
PTT
measures most factors except 7 and 13 (so does NOT pick up factor 7 def)
ACT goals
Activated clotting time
150-200 sec for AC
> 460 for cardioplum bypass
MCC surgical bleeding
Incomplete hemostasis
MCC congenital bleeding disorder
vWF disease
Types 1 (MCC) and 2 are AD, 3 (severe) is autosomal recessive
vWF
Links Gp1b receptor on platelets to collagen
vWF disease labs
INR/PT normal
PTT normal or abnormal
Prolonged bleeding time (ristocetin test)
vWF disease types
- MCC, reduced vWF quantity, tx recombinant 8:vWF, DDAVP, cryo
- defect, vWF molecule not working well, tx recombinant 8:vWF, cryo
- absent (rare), tx recombinant 8:vWF, cryo; DDAVP WILL NOT WORK
Hemophilia A
8 deficiency
sex-linked recessive
need levels 100% preop
80-100% for 10-14 days after surgery
prolonged PTT, normal PT
factor 8 crosses placenta so newborns may not bleed at circumcision
Join bleed: DO NOT ASPIRATE: tc ice, ROM exercises, factor 8 concentrate or cryo
Epistatxis or ICH or hematuria: tx recombinant factor 8 or cryo
Hemophilia B
9 deficiency
sex-linked recessive
need level 100% preop
30-40% for 2-3 days after surgery
prolonged PTT, normal PT
Tx recombinant factor 9 or FFP
Factor 7 deficiency
Prolonged PT/INR, normal PTT
Tx: recombinant factor 7 or FFP